GENZ
GENZ Articles
Genzyme Corp. (NASDAQ: GENZ) has taken steps to remedy its situation with the FDA and to remedy its image. Genzyme issued some new guidance with an investor update and said it would discard the...
Published:
We have some very unusual developments that came late in the week that we want you to keep on your watch lists for the coming week. We also included the big events coming down the pipe for next...
Published:
Last Updated:
These are the top ten analyst upgrades and downgrades we have seen from Wall Street firms early this Monday morning: Allergan (AGN) Raised to Outperform at Baird. Burger King (BKC) Cut to Neutral at...
Published:
It always good to keep watch lists. There were some key issues over the last week that will have important implications for the coming week (or weeks). This is definitely the case for Tyson Foods...
Published:
Last Updated:
Novartis AG (NYSE: NVS) shares are at session highs and well of the lows of the day in the early afternoon Thursday after Japan okayed one of the company’s human growth hormones, the first approval...
Published:
Reuters: The US faces a long period of economic stagnation. Reuters: Obama will release plans for a financial market overhaul. Reuters: The White House will not help California fix its...
Published:
Last Updated:
Biotech Genzyme Corp. (Nasdaq: GENZ) reported on Friday that it has received European approval for Renvela, a newer version of its Renagel drug to help control phosphate levels in the blood of...
Published:
Last Updated:
These are some of the top analyst upgrades and positive research calls we have seen this Tuesday morning from Wall Street: Aruba Networks (ARUN) Raised to Neutral at JPMorgan. CommScope (CTV) Raised...
Published:
Piper Jaffray & Co. initiates coverage on Genzyme (Nasdaq: GENZ) with a Buy rating and $86 price target, citing steady growth with highly achievable catalysts. Piper analyst says, “We believe...
Published:
These are ten of the top impact research calls with upgrades and downgrades from Wall Street early this Friday morning: Amgen (AMGN) Raised to Overweight at JPMorgan. ConocoPhillips (COP) Raised to...
Published:
These are some of the top pre-market early bird analyst upgrades and downgrades from Wall Street this Monday morning: Amazon.com (AMZN) Raised to Buy at Piper Jaffray. Best Buy (BBY) Raised to...
Published:
GE (GE) Growing concern that financial division will have heavy write-offs. Drops to $6.85 from a 52-week high of $38.52. MetLife (MET) One of many insurance companies being pulled down by AIG...
Published:
Last Updated:
These are some of the top analyst downgrades or cautious analyst calls we have seen from Wall Street this Tuesday morning: BP (BP) Cut to Market Perform at Bernstein. Credit Suisse (CS) Cut to...
Published:
Last Updated:
Biogen Idec Inc. (NASDAQ: BIIB) is set to report earnings on Friday morning. What many investors probably want to know is if these results — or more importantly its guidance — show that this...
Published:
Last Updated:
There may be some speculation that drug giant Pfizer Inc. (NYSE: PFE) is looking at expansion through acquisitions. The FT reported that the world’s largest pharmaceutical company is willing to...
Published:
Last Updated: